Lung Cancer News and Research

Latest Lung Cancer News and Research

Preliminary study for detection of pancreatic cancer shows encouraging results

OTraces, Inc., a molecular diagnostics company specializing in early cancer detection, has announced completion of a preliminary study for detection of pancreatic cancer.

1 Aug 2019

Simple, accurate, and fast: the new "sniff-cam" disease detector

It’s not just about garlic on the breath any more; your breath could now help reveal a variety of diseases. The science behind it is that the human body excretes a number of volatile compounds through the breath, and the type and proportion of these vary with the kind of disease.

1 Aug 2019

Highly sensitive 'sniff-cam' to detect disease biomarkers

Having bad breath can mean someone ate a smelly lunch, but it could indicate that the person is sick. Various scent compounds have been linked to illnesses such as diabetes, lung cancer and Parkinson's disease, leading scientists to develop technology that measures these substances.

31 Jul 2019

GlobalData: Lung cancer incidence rates are decreasing for men, but increasing among women

As World Lung Cancer Day approaches on August 1st, it serves as a reminder that lung cancer remains a major public health issue, particularly for women.

29 Jul 2019

Study finds specific direct targets for lung cancer treatment

A team of researchers at the Salk Institute has found two therapeutic targets for the deadly type of lung cancer, non-small-cell lung carcinomas (NSCLCs), which accounts for 85 percent of all lung cancer cases. They believe that the breakthrough discovery could pave the way for the development of new treatments for a majority of lung cancer patients.

29 Jul 2019

Scientists discover novel mechanism of action for NK cells in checkpoint inhibitor for cancer

PD-L1 checkpoint inhibitors are a powerful and growing form of immunotherapy used to treat melanoma, kidney cancer, head and neck cancers, Hodgkin's lymphoma and other cancers.

27 Jul 2019

Salk study unlocks new way to target hard-to-treat cancers

Now, a new Salk Institute study, published on July 24, 2019, in the journal Science Advances, shows that researchers could target these hard-to-treat cancers by pursuing drugs that keep a cellular "switch," called CREB, from triggering tumor growth.

25 Jul 2019

Scientists identify new way to target bottleneck for cancer cell growth

The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists at Winship Cancer Institute of Emory University have identified a way of targeting ribonucleotide reductase that may avoid the toxicity of previous approaches, informing focused drug discovery efforts.

23 Jul 2019

Harvesting hidden information in chest X-rays using AI to predict mortality

The most frequently performed imaging exam in medicine "the chest X-ray" holds 'hidden' prognostic information that can be harvested with artificial intelligence, according to a study by scientists at Massachusetts General Hospital.

22 Jul 2019

Johns Hopkins designs criteria for diagnostic imaging tests

On June 30, the Centers for Medicare & Medicaid Services (CMS) announced that the Johns Hopkins University School of Medicine has been designated a so-called “qualified provider-led entity.”

From Johns Hopkins Medicine 19 Jul 2019

Mathematical model helps quantify metastatic cell behavior

Cancer metastasis is a difficult stage to battle, especially if cancer cells are proliferating at a rapid pace. A new study reveals that metastatic cells change their shape to spread to other parts of the body. Researchers formulated a mathematical model to study metastatic cell behavior and similar cellular systems.

17 Jul 2019

Heart disease is still the number 1 killer in Australia, according to latest figures

The latest report from the Australian Institute of Health and Welfare reveals that heart disease and heart attacks are still the most common causes of death.

17 Jul 2019

MGH researchers identify potential markers of lung cancer

By examining both blood samples and tumor tissues from patients with non-small-cell lung cancer, investigators at Massachusetts General Hospital have identified markers that can distinguish between major subtypes of lung cancer and can accurately identify lung cancer stage.

16 Jul 2019

Alternate cell growth pathway could open door to new treatments for metastatic cancers

While researchers have a basic understanding of how primary cancer cells grow, less is known about metastasis, the deadly process by which cancers spread.

12 Jul 2019

Adding immunotherapy after initial treatment improves survival in metastatic NSCLC patients

Treating metastatic non-small cell lung cancer patients with the immunotherapy drug pembrolizumab after they've completed locally ablative therapy – meaning all known sites of their cancer were either treated with surgery, radiation, or other definitive treatments – almost tripled the median progression-free survival compared to the historical average.

12 Jul 2019

Researchers identify potential drug target for multiple cancer types

A research team headed by scientists at University of California San Diego School of Medicine and the Ludwig Institute for Cancer Research at UC San Diego has identified an enzyme involved in remodeling the plasma membrane of multiple cancer cell types that is critical to both survival of tumors and their uncontrolled growth.

11 Jul 2019